These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1151699)

  • 21. Sustained-release tablets of indomethacin-loaded microcapsules: preparation, in vitro and in vivo characterization.
    Lu B; Wen R; Yang H; He Y
    Int J Pharm; 2007 Mar; 333(1-2):87-94. PubMed ID: 17081709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. On the stability of the liquid-crystalline lamellar lecithin-water system.
    Colbow K; Jones BL
    Biochim Biophys Acta; 1974 Apr; 345(1):91-101. PubMed ID: 4838206
    [No Abstract]   [Full Text] [Related]  

  • 23. Crystal growth formation in melt extrudates.
    Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
    Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Solvent influences on metastable polymorph lifetimes: real-time interconversions using energy dispersive X-ray diffractometry.
    DeMatos LL; Williams AC; Booth SW; Petts CR; Taylor DJ; Blagden N
    J Pharm Sci; 2007 May; 96(5):1069-78. PubMed ID: 17455330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Solubility of molecular crystals: polymorphism in the light of solubility theory.
    Bennema P; van Eupen J; van der Wolf BM; Los JH; Meekes H
    Int J Pharm; 2008 Mar; 351(1-2):74-91. PubMed ID: 17980982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparative biopharmaceutical study of tegalide].
    Lopatina NB; Lebedeva MN
    Med Parazitol (Mosk); 2000; (1):27-9. PubMed ID: 10808715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stabilization of solid dispersions of nimodipine and polyethylene glycol 2000.
    Urbanetz NA
    Eur J Pharm Sci; 2006 May; 28(1-2):67-76. PubMed ID: 16472995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Significance of controlling crystallization mechanisms and kinetics in pharmaceutical systems.
    Rodríguez-Hornedo N; Murphy D
    J Pharm Sci; 1999 Jul; 88(7):651-60. PubMed ID: 10393562
    [No Abstract]   [Full Text] [Related]  

  • 29. [Pharmaceutical suspensions, an effective drug form].
    Bashuara GS; Safiulina ZR; Pertsev IM; Duchidze NV
    Farm Zh; 1975; 30(6):27-34. PubMed ID: 765146
    [No Abstract]   [Full Text] [Related]  

  • 30. In Vitro and In Vivo Characterization of Drug Nanoparticles Prepared Using PureNano™ Continuous Crystallizer to Improve the Bioavailability of Poorly Water Soluble Drugs.
    Tahara K; Nishikawa M; Matsui K; Hisazumi K; Onodera R; Tozuka Y; Takeuchi H
    Pharm Res; 2016 Sep; 33(9):2259-68. PubMed ID: 27301372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Carboxyvinyl polymers in pharmaceutical technology].
    Perotti AG
    Farmaco Prat; 1970 Nov; 25(11):651-88. PubMed ID: 5497424
    [No Abstract]   [Full Text] [Related]  

  • 32. Quantification of crystalline forms in active pharmaceutical ingredient and tablets by X-ray powder diffraction.
    Cooper VB; Pearce GE; Petts CR
    J Pharm Pharmacol; 2003 Sep; 55(9):1323-9. PubMed ID: 14604477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Solid crystal suspensions containing griseofulvin--preparation and bioavailability testing.
    Reitz E; Vervaet C; Neubert RH; Thommes M
    Eur J Pharm Biopharm; 2013 Feb; 83(2):193-202. PubMed ID: 23108185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deliquescence of pharmaceutical systems.
    Mauer LJ; Taylor LS
    Pharm Dev Technol; 2010 Dec; 15(6):582-94. PubMed ID: 19895256
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disproportionation of a crystalline citrate salt of a developmental pharmaceutical compound: characterization of the kinetics using pH monitoring and online Raman spectroscopy plus quantitation of the crystalline free base form in binary physical mixtures using FT-Raman, XRPD and DSC.
    Skrdla PJ; Zhang D
    J Pharm Biomed Anal; 2014 Mar; 90():186-91. PubMed ID: 24378612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stability of the crystalline form of cefaclor monohydrate and its pharmaceutical preparations.
    Medenecka B; Jelińska A; Zajac M; Bałdyka M; Juszkiewicz K; Oszczapowicz I
    Acta Pol Pharm; 2009; 66(5):563-9. PubMed ID: 19894653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of formulated ingredients on rapidly disintegrating oral tablets prepared by the crystalline transition method.
    Sugimoto M; Narisawa S; Matsubara K; Yoshino H; Nakano M; Handa T
    Chem Pharm Bull (Tokyo); 2006 Feb; 54(2):175-80. PubMed ID: 16462059
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [On the polymorphism of Barbiturates in powers and tablets. Part 5: The dissolution of recrystallized barbital substances and their release from tablet (author's transl)].
    Hollenbach K; Pintye-Hódi K; Kedvessy G
    Pharmazie; 1980 Feb; 35(2):95-8. PubMed ID: 7384189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kinetics of crystallization in hard-sphere colloidal suspensions.
    Dixit NM; Zukoski CF
    Phys Rev E Stat Nonlin Soft Matter Phys; 2001 Oct; 64(4 Pt 1):041604. PubMed ID: 11690037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fabrication, solid state characterization and bioavailability assessment of stable binary amorphous phases of Ritonavir with Quercetin.
    Dengale SJ; Hussen SS; Krishna BS; Musmade PB; Gautham Shenoy G; Bhat K
    Eur J Pharm Biopharm; 2015 Jan; 89():329-38. PubMed ID: 25542681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.